AKT1 and neoplasm: Either loss of PTEN or activation of Akt resulted in an increased sensitivity to the rapalogue CCI-779 in a panel of brain, prostate, breast cancer cell lines, and human tumours implanted in athymic nude mice (Yu et al, 2001).